CapsoVision, Inc. (CV) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
CapsoVision, Inc. (CV) operates in the Healthcare sector, specifically the Medical - Equipment & Services industry, with a market capitalization near $336.8M, listed on NASDAQ, employing roughly 90 people, carrying a beta of -2.62 to the broader market. Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics Led by Kang-Huai Wang, public since 2001-09-03.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for CV as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.